Matrix metalloproteinase inhibitors: a review.

Matrix metalloproteinase inhibitors: a review. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Matrix metalloproteinase inhibitors: a review. Abstract Text:

S A Watson,G Tierney,

The matrix metalloproteinases (MMPs) are a family of closely related, zinc-dependent proteolytic enzymes. Collectively, they are capable of degrading all the components of the extracellular matrix and as such are involved in a number of physiological and pathological processes. The extracellular matrix is the principal barrier to tumour growth and spread, and there is evidence that MMPs play a role in the processes of tumour growth and metastasis. Therefore, inhibitors of MMPs may be of value in the treatment of malignant disease. There exist naturally occurring inhibitors of these enzymes known as 'tissue inhibitors of MMPs', or TIMPs. Although there have been considerable preclinical studies on these inhibitors, they are as yet unavailable for use as therapeutic drugs. Research in this field has focused largely on the development of low molecular weight (<500D) synthetic inhibitors of MMPs. In this review we focus on the various subgroups of MMP inhibitors now available, their preclinical evaluation and the limited information available from preliminary clinical trials. We comment on the suitability of the preclinical models used and the difficulty in designing clinical trials of these drugs. We focus on future developments which may involve the use of these drugs in combination with existing chemotherapeutic regimens to achieve a synergistic effect.

Matrix metalloproteinase inhibitors: a review. Publishing Authors By Initials

SA Watson,G Tierney,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Matrix metalloproteinase inhibitors: a review. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: BioDrugs : clinical immunotherapeutics, biopharmac

VOLUME: 9

Page Numbers: 325-35

Journal Abbreviation:

ISSN: 1173-8804

DAY: 20

MONTH: Apr

YEAR: 1998

Matrix metalloproteinase inhibitors: a review. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9705305

Matrix metalloproteinase inhibitors: a review. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Matrix metalloproteinase inhibitors: a review. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Matrix metalloproteinase inhibitors: a review.

AFFILIATION: Cancer Studies Unit, Department of Surgery, Queens Medical Centre, University of Nottingham, Nottingham, England.

Country: New Zealand

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: BioDrugs

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Matrix metalloproteinase inhibitors: a review Related Publications

• A modular flow reactor for performing Curtius rearrangements as a continuous flow process.
• A single health status question had important prognostic value among outpatients with chronic heart failure.
• Autism: The role of cholesterol in treatment.
• Characteristics of HIV infected patients cared for at "academic model for the prevention and treatment of HIV/AIDS" clinics in western Kenya.
• Characteristics of injuries presenting to a rural health centre in western Kenya.
• Commentary.
• Cooking up an open source EMR for developing countries: OpenMRS - a recipe for successful collaboration.
• Costs, service differences, and prices in private clinical laboratories.
• Creating communities in cyberspace: pro-anorexia web sites and social capital.
• Editor-in-Chief's Introduction.
• Endoscopic electronic medical record systems.
• Improving treatment of late life depression in primary care: a randomized clinical trial.
• Information technology in PBRNs: the Indiana University Medical Group Research Network (IUMG ResNet) experience.
• Laser beam active tracking for specular objects to fractions of Lambda/D.
• Longitudinal study of depression and health services use among elderly primary care patients.
• Matrix metalloproteinase inhibitors: a review.
• Measuring Impact/Peak Acceleration and Dynamic Stabilization of the Head and Neck During Sport Activity: 240: 3:45 PM-4:10 PM.
• Meet Richard Tierney D.D.S. dentist/rancher.
• Narrow band imaging and multiband imaging.
• New nonionic detergents derived from epoxidized oils. 3.
• Online open.
• Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya.
• Postdicting verbal IQ of elderly individuals.
• Profiling disruptive patient incidents.
• Regioregular poly(3-hexyl)selenophene: a low band gap organic hole transporting polymer.
• Research governance.
• Risk-based evaluation of thromboprophylaxis among surgical inpatients: are low risk patients treated unnecessarily?
• Seeing the person.
• Smith-Lemli-Opitz syndrome and autism spectrum disorder.
• X-ray absorption spectroscopy of the zinc-binding sites in the class B2 metallo-beta-lactamase ImiS from Aeromonas veronii bv. sobria.